Graphic: Vioxx Legal Resources.com

Image: Gavel and Law Books


Graphic: Summary tab
On September 30, 2004, the international prescription drug company Merck announced the worldwide withdrawal of the arthritis medication Rofecoxib, sold in most countries under the brand name Vioxx, because a study showed an increased risk of heart attack and stroke. Patients who have suffered injuries due to Vioxx have filed litigation against Merck for failing to recall the drug when it first learned of Vioxx's dangerous side effects.

To contact in confidence an experienced personal injury attorney at Lieff Cabraser working on the Vioxx lawsuit, click here.


Graphic: International
The painkiller Vioxx was marketed throughout the world, sold in many countries under the name Vioxx and in others as Ceoxx. Lieff Cabraser is working with attorneys and solicitors in:

Argentine flag Argentina
Flag Austria Austria
Flag Canada Canada
Flag Ireland Ireland
Flag Italy Italy
Flag South Africa South Africa
Flag United Kingdom United
         Kingdom

and other countries to bring litigation against Merck in U.S. courts for patients suffering heart attacks and strokes from Vioxx. If you are visiting this website from outside the U.S., please click here to contact an attorney regarding your experiences with Vioxx or Ceoxx.

 


Our Offices

  
hair drug test false positive

San Francisco
Embarcadero Center West
275 Battery Street, Suite 3000
San Francisco, CA
Tel.
Fax.

Map/Directions

  
  

New York
780 Third Avenue, 48th Floor
New York, NY
Tel.
Fax.

Map/Directions

  
Washington D.C.
1100 New York Ave., N.W.
Suite 1080 - West Tower
Washington, DC
Tel.
Fax.

Map/Directions
 
  
Beverly Hills
9401 Wilshire Boulevard
Twelfth Floor
Beverly Hills, CA
Tel.
Fax.

Map/Directions
  
Nashville
3319 West End Ave., Ste 600
Nashville, TN
Tel.
Fax.

Map/Directions

Images: Supreme Court, Law Books, Scales and pill images
Lieff Cabraser Heimann & Bernstein, LLP
E-mail: mail
Firm Website: http://www.lieffcabraser.com

Trademark Notice
          "Vioxx" is a registered trademark of Merck. Lieff Cabraser Heimann & Bernstein, LLP is in no way affiliated with Merck, and the Vioxx trademark is used solely for informational purposes.

Copyright © 2004-2005 Lieff Cabraser Heimann & Bernstein, LLP

Graphic: Latest News
"Banned Report on Vioxx Published" Los Angeles Times, Jan. 25, 2005
 
A report on Vioxx risks previously blocked by the FDA was published online Monday after the agency withdrew its opposition. The study found that as many as 140,000 cases of heart disease in the United States and as many as 56,000 deaths were caused by the painkiller Vioxx during the five years that it was on the market.
  
To read more press articles on the Vioxx recall and Vioxx class action lawsuit, click here.


Graphic: Verdicts & Settlements header
Lieff Cabraser has participated in twenty-three $100 million-plus settlements and verdicts. To read a summary, click here.


Graphic: Press Articles
News
Click here to read recent press articles on the Vioxx recall and Vioxx lawsuits.


Graphic: Timeline
Timeline
Read about key events in the Vioxx recall and Vioxx lawsuit by clicking here.



Vioxx Recall Lawsuits and Vioxx Side Effects: 2004 Update News

vioxxlegalresources.com v 4_3